FDA to Establish Monograph for Over-the-Counter Dental Plaque and Gingivitis Treatments

Summary

The FDA is issuing an advance notice of proposed rulemaking to establish conditions for over-the-counter (OTC) drug products that reduce or prevent dental plaque and gingivitis, following recommendations from the Dental Plaque Subcommittee of the Nonprescription Drugs Advisory Committee (NDAC).